Liposomes as targeted drug delivery systems in the treatment of breast cancer.
about
Modeling particle shape-dependent dynamics in nanomedicineUltrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors.Steric environment around acetylcholine head groups of bolaamphiphilic nanovesicles influences the release rate of encapsulated compounds.Zwitterionic chitosan derivatives for pH-sensitive stealth coating.Urea immunoliposome inhibits human vascular endothelial cell proliferation for hemangioma treatment.Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acidPEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.The shape of things to come: importance of design in nanotechnology for drug delivery.Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomesDNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasisShape-specific polymeric nanomedicine: emerging opportunities and challenges.Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel.Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR antibody.Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma.
P2860
Q30498368-D2B1CA3E-181D-4262-944A-2099138D56A4Q30514138-166125E3-8489-4E20-818D-233B9D172481Q30568293-A09A606E-E0E9-4734-BA9E-426669364FF7Q34139159-531ED477-D120-45B1-AE4B-82CB2F080433Q35050948-B4AC31C1-8D09-4B8E-93C5-57877286BC17Q35209956-5190FEBC-5129-44EC-9384-04390063581CQ35377803-87427208-EEDB-4E8F-B3B0-CDC8E5F21207Q36128678-32AE150B-059B-4CB2-8FA1-0DDB7E8570E1Q36239594-81A13B99-7C90-49AC-B8D7-47C3C0D02273Q37106270-BCBEFF56-1BF3-487C-977B-0545B25CAA95Q37829181-15B534FA-4E8D-4C3A-8231-97E4CF98B5EEQ39185708-8670D4A5-BCBB-4F14-9CEC-0DC405ACA2CEQ42364445-D6AA506E-884F-4499-AEEA-0BE3C9CAE852Q52570980-C3949262-E577-4537-88AB-E67D8F0EE2D0
P2860
Liposomes as targeted drug delivery systems in the treatment of breast cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Liposomes as targeted drug delivery systems in the treatment of breast cancer.
@ast
Liposomes as targeted drug delivery systems in the treatment of breast cancer.
@en
type
label
Liposomes as targeted drug delivery systems in the treatment of breast cancer.
@ast
Liposomes as targeted drug delivery systems in the treatment of breast cancer.
@en
prefLabel
Liposomes as targeted drug delivery systems in the treatment of breast cancer.
@ast
Liposomes as targeted drug delivery systems in the treatment of breast cancer.
@en
P2093
P2860
P1476
Liposomes as targeted drug delivery systems in the treatment of breast cancer.
@en
P2093
Anabousi S
Ehrhardt C
Ravi Kumar MN
P2860
P304
P356
10.1080/10611860600809112
P577
2006-06-01T00:00:00Z